Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.54 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.54 |
| ▸ | ACP1 | P24666 | 4/20 | 0.54 |
| ▸ | PTPRF | P10586 | 2/20 | 0.54 |
| ▸ | PTPRB | P23467 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ALPL | P05186 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.50 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25196342 | 0.85 | PTPN1 (0.68) | CA9PTPN1PTPN2ACP1PTPRF | |
| SCHEMBL15815473 | 0.81 | MAPK1 (0.59) | PTPN1PTPN2ACP1PTPRFPTPRB | |
| SCHEMBL15815472 | 0.81 | MAPK1 (0.59) | PTPN1PTPN2ACP1PTPRFPTPRB | |
| SCHEMBL15815471 | 0.81 | MAPK1 (0.59) | PTPN1PTPN2ACP1PTPRFPTPRB | |
| SCHEMBL25214975 | 0.79 | PTPN1 (0.65) | PTPN1PTPN2ACP1PTPRFPTPRB | |
| SCHEMBL25216522 | 0.78 | PTPN1 (0.71) | PTPN1PTPN2ACP1PTPRFPTPRB | |
| SCHEMBL25197112 | 0.76 | MAPT (0.65) | CA9PTPN1MAPTMAPK1ALDH1A1 | |
| SCHEMBL2547330 | 0.76 | PIM1 (0.77) | CA9MEN1KMT2AMAPTMAPK1 | |
| SCHEMBL2547331 | 0.76 | PIM1 (0.77) | CA9MEN1KMT2AMAPTMAPK1 | |
| SCHEMBL25191741 | 0.75 | PTPN1 (0.69) | PTPN1PTPN2ACP1PTPRFPTPRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | CA9 1508/4885PTPN1 1308/4885PTPN2 1928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.